A new intraoperative classification system enhances pancreatic surgery for benign and low-grade tumors.

• 122 patients underwent robotic resections with IPDECT; type I defects had a 10.6% overall complication rate including 8.5% for postoperative pancreatic fistula.
• Type IV defects had longer operations (mean 127.6 min) yet only 5.9% complications.

Standardizing decision-making may enhance patient outcomes and preserve pancreatic function.

• No tumor recurrence or metabolic issues were reported within 1 to 4 years post-surgery.